156 related articles for article (PubMed ID: 38392055)
1. Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer.
Mellor R; Girgis CM; Rodrigues A; Chen C; Cuan S; Gambhir P; Perera L; Veness M; Sundaresan P; Gao B
Curr Oncol; 2024 Feb; 31(2):828-838. PubMed ID: 38392055
[TBL] [Abstract][Full Text] [Related]
2. Effect of prophylactic tube feeding in head and neck cancer patients with high Mallampati score undergoing definitive concurrent chemoradiotherapy.
Lu CH; Hsu CC; Su PH; Lin SY; Yeh KY; Hsueh SW; Chang JT; Wang HM; Hung YS; Chou WC
Support Care Cancer; 2023 Jun; 31(7):384. PubMed ID: 37289404
[TBL] [Abstract][Full Text] [Related]
3. Objective evaluation of nutritional status using the prognostic nutritional index during and after chemoradiotherapy in Japanese patients with head and neck cancer: a retrospective study.
Fujiwara D; Tsubaki M; Takeda T; Miura M; Nishida S; Sakaguchi K
Eur J Hosp Pharm; 2021 Sep; 28(5):266-270. PubMed ID: 34426479
[TBL] [Abstract][Full Text] [Related]
4. Impact of Diabetes Mellitus on Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy.
Kuo HC; Chang PH; Wang CH
Sci Rep; 2020 May; 10(1):7702. PubMed ID: 32382160
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy.
Chou WC; Chang PH; Chen PT; Wang HM; Yeh KY; Lu CH; Hung YS; Tung-Chieh Chang J; Tsang NM; Ho YW; Chen SY; Lee SH; Hung CY; Wang LJ; Liao KC; Lin CH; Tang WR; Lin YC
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):602-611. PubMed ID: 31987971
[TBL] [Abstract][Full Text] [Related]
6. Outcome of bimodality definitive chemoradiation does not differ from that of trimodality upfront neck dissection followed by adjuvant treatment for >6 cm lymph node (N3) head and neck cancer.
Chen WY; Chen TC; Lai SF; Liang TH; Huang BS; Wang CW
PLoS One; 2019; 14(12):e0225962. PubMed ID: 31794576
[TBL] [Abstract][Full Text] [Related]
7. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy.
Nugent B; Lewis S; O'Sullivan JM
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD007904. PubMed ID: 23440820
[TBL] [Abstract][Full Text] [Related]
8. Characterization of changes in total body composition for patients with head and neck cancer undergoing chemoradiotherapy using dual-energy x-ray absorptiometry.
Jackson W; Alexander N; Schipper M; Fig L; Feng F; Jolly S
Head Neck; 2014 Sep; 36(9):1356-62. PubMed ID: 23970480
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy.
Chou WC; Lai CC; Hung CY; Hsueh SW; Yeh KY; Lu CH; Tsang NM; Chang PH; Ho YW; Chen SY; Lin YC; Hung YS
Cancer Control; 2022; 29():10732748211045276. PubMed ID: 34994207
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
[TBL] [Abstract][Full Text] [Related]
11. Assessing cumulative acute toxicity of chemoradiotherapy in head and neck cancer with or without induction chemotherapy.
Shah BA; Qureshi MM; Logue JM; Cooley TP; Zaner KS; Jalisi S; Truong MT
Am J Otolaryngol; 2017; 38(4):456-461. PubMed ID: 28427799
[TBL] [Abstract][Full Text] [Related]
12. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.
Chen YH; Lu HI; Chien CY; Lo CM; Wang YM; Chou SY; Su YY; Shih LH; Li SH
Sci Rep; 2017 Jan; 7():41785. PubMed ID: 28134308
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01).
Lee YG; Kang EJ; Keam B; Choi JH; Kim JS; Park KU; Lee KE; Kwon JH; Lee KW; Kim MK; Ahn HK; Shin SH; Kim HR; Kim SB; Yun HJ
BMC Cancer; 2020 Aug; 20(1):813. PubMed ID: 32854649
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the pretreatment geriatric nutritional risk index for predicting severe adverse events in patients with head and neck cancer treated with chemoradiotherapy.
Nakayama M; Ohnishi K; Adachi M; Ii R; Matsumoto S; Nakamura M; Miyamoto H; Hirose Y; Nishimura B; Tanaka S; Wada T; Tabuchi K
Auris Nasus Larynx; 2022 Apr; 49(2):279-285. PubMed ID: 34509306
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
16. Role of primary tumor volume and metastatic lymph node volume in response to curative effect of definitive radiotherapy for locally advanced head and neck cancer.
Mao W; Zhang T; Li L; Peng S; Gong H; Li M
Eur J Med Res; 2024 Feb; 29(1):98. PubMed ID: 38311769
[TBL] [Abstract][Full Text] [Related]
17. Functional outcomes of chemoradiation in patients with head and neck cancer.
Tulunay-Ugur OE; McClinton C; Young Z; Penagaricano JA; Maddox AM; Vural E
Otolaryngol Head Neck Surg; 2013 Jan; 148(1):64-8. PubMed ID: 22951428
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan.
Chen JH; Yen YC; Liu SH; Yuan SP; Wu LL; Lee FP; Lin KC; Lai MT; Wu CC; Chen TM; Chang CL; Chow JM; Ding YF; Lin MC; Wu SY
Medicine (Baltimore); 2016 Feb; 95(7):e2845. PubMed ID: 26886647
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Nutritional and Clinical Outcomes in Patients with Head and Neck Cancer Undergoing Chemoradiotherapy Utilizing Prophylactic versus Reactive Nutrition Support Approaches.
Brown TE; Banks MD; Hughes BGM; Lin CY; Kenny LM; Bauer JD
J Acad Nutr Diet; 2018 Apr; 118(4):627-636. PubMed ID: 27986517
[TBL] [Abstract][Full Text] [Related]
20. Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: A phase II randomized, double-blind study.
Dechaphunkul T; Arundon T; Raungkhajon P; Jiratrachu R; Geater SL; Dechaphunkul A
Clin Nutr; 2022 Feb; 41(2):433-440. PubMed ID: 35007812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]